OMEROS CORP Gain (Loss) Related to Litigation Settlement
OMEROS CORP (OMER) reported Gain (Loss) Related to Litigation Settlement of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2016-03-15
- OMEROS CORP gain (loss) related to litigation settlement for the quarter ending 2013-12-31 was $12.50M, a 216.22% increase year-over-year.
- OMEROS CORP gain (loss) related to litigation settlement for the quarter ending 2013-09-30 was $0.00.
- OMEROS CORP gain (loss) related to litigation settlement for the quarter ending 2012-12-31 was $3.95M.
- OMEROS CORP gain (loss) related to litigation settlement for the quarter ending 2012-09-30 was -$3.95M.
- OMEROS CORP gain (loss) related to litigation settlement for fiscal 2015 was $0.00.
- OMEROS CORP gain (loss) related to litigation settlement for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- OMEROS CORP gain (loss) related to litigation settlement for fiscal 2013 was $12.50M.
- OMEROS CORP gain (loss) related to litigation settlement for fiscal 2012 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 | |||
| 2013-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $12.50M derived: sum of 2 quarters · filed 2016-03-15 | $12.50M 10-K · filed 2016-03-15 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | ||
| 2012-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | |
| 2012-09-30 | -$3.95M 10-Q · filed 2013-11-07 | -$3.95M 10-Q · filed 2013-11-07 | ||
| 2011-12-31 | $0.00 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |